A favorite topic of mine over the years is Japan. In this column, I have covered different aspects of the Japanese pharmaceutical industry and biotech markets (3/10/03, 8/18/03, 3/28/05). I had the good fortune to return to Japan for the Bio-Jan 2006 Conference
in September after a three-yea......Full article >>>
Mayor Daley's head of transportation accompanied us on this trip to Japan and came away wowed by the Japanese approach to mass transit. Many more people in Japan use mass transit, a combination of an extensive network of easy-to-use subways and trains, including the high-speed bullet trains - the Shinkansen - than in Chicago.
Upon arriving to Osaka for the Bio-Japan Conference, att......Full article >>>
e over-the-counter (OTC) drugs.
This level compares with the U.S. market, which had pharmaceutical sales of $240.3 billion in 2005, represented 44 percent of the total market, and grew three percent. So the U.S. market is about four times as large as the Japanese market, but remember that the U.S. population is about three times that of Japan (the Japanese population, at about 127 million......Full article >>>
but bi-annual price reductions of eight to 12 percent (although there is talk of reducing prices on an annual basis.) This is another factor driving Japanese companies to merge for greater critical mass (particularly in R&D) and expand their presence in the United States.
The Japanese pharma industry has been slow to embrace the successful pathway used by its automotive counterparts. Neve......Full article >>>
|Shionogi & Co. (Osaka)||$1.7||<1%>||$0.2||+20%|
|49||Dainippon Sumitomo Pharma Co. ** (Osaka)||New Jersey||$1.6||+30%||$0.1||122%|
Source: MedAd News
, Sept. 2006
*now owned by Hoffman LaRoche
**represents merger during last 2 years
Note: sales number vary slig......Full article >>>
Full article >>>
ties have gotten on the biotech bandwagon. University professors now are allowed to spend time with start-up companies and share in revenue from out-licensed technologies.
What struck me at the Bio-Japan meeting was the lack of Japanese "Big Pharma" presence at the meeting (very few were there). They seem to be missing out on the growth of their own home-grown market as a source of innova......
Full article >>>
lly, the Japanese External Trade Office has a large regional presence in the Midwest with its Chicago office. JETRO played a major role at the Bio-Japan event, fostering partnering sessions and receptions.
I think the time is right for Illinois and the Midwest to build further ties to both the Japanese biotech industry and the second and third tier Japan......
Full article >>>
hnology Network, LLC. (WTN). WTN, LLC, accepts no legal liability or responsibility for any claims made or opinions expressed herein.......
Full article >>>
Source:wistechnology.com By Michael Rosen 10/23/06
Related biology technology :
1. Japanese delegates highlight Wisconsin at BIO Chicago
2. Japanese telecom opens liason office at UW-Platteville
3. Promega, Japanese lab announce partnership
4. Japanese institute installs Imago system
5. Wisconsin biotechs plan Japan trade mission
6. Sonic Foundry makes Japanese version of lead product
7. OpGen forges agreement with Japanese importer
8. Japanese biotech is booming and linked with Midwest
9. Japans pharma mergers will trickle to the Midwest
10. Japanese institute will develop for UWs Croquet platform
11. Doyles Japan trip opens doors and minds for Wisconsin
(Date:12/8/2016)... 8, 2016 HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), ... and plans to commercialize innovative therapeutics for patients ... stock were approved for trading on the OTCQX ... the OTCQX, effective today, under the ticker symbol ... market, companies must meet high financial standards, follow ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. ... billion KRW (US $18.9M) Series A financing. This financing ... G.N. Tech Venture and SNU Bio Angel. This new ... 30.5 billion KRW (US $27.7M) since its founding in ... to bolster the development and commercialization of its immuno-oncology ...
(Date:12/8/2016)... 2016 Biocept, Inc . (NASDAQ: ... clinically actionable liquid biopsy tests to improve the ... featuring its Target Selector™ Circulating Tumor Cell platform ... detection of actionable biomarkers in patients with metastatic ... Sara Cannon Research Institute (SCRI), the research arm ...
(Date:12/7/2016)... McLean, VA (PRWEB) , ... December 07, 2016 ... ... peer-reviewed medical journal has concluded that “in the setting of previously treated, advanced ... Further refinement in defining the optimal patient population and timing of blood sampling ... Breaking Biology Technology:
(Date:11/14/2016)... 14, 2016 xG Technology, Inc. ("xG" or the ... wireless communications for use in challenging operating environments, announced ... 2016. Management will hold a conference call to discuss ... Eastern Time (details below). Key Recent Accomplishments ... million binding agreement to acquire Vislink Communication Systems. The ...
(Date:6/22/2016)... 2016 The American College of Medical Genetics and Genomics ... as one of the fastest-growing trade shows during the ... Bellagio in Las Vegas . ... growth in each of the following categories: net square feet ... of attendees. The 2015 ACMG Annual Meeting was ranked 23 ...
(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ... Breaking Biology News(10 mins):